Innovative Therapeutics and Diagnostics
Our mission is to develop, investigate, and implement leading-edge technologies for novel immunotherapeutics, new antimicrobial agents, and advanced molecular detection systems for the diagnosis, treatment, and prevention of life-threatening infections in immunocompromised pediatric and adult patients with cancer, transplantation, autoimmune diseases, and other immunodeficiencies.
years of experience
The global challenges of multidrug-resistant microbial pathogens and the evolution of SARSCoV-2, in an ever-expanding population of immunocompromised patients with cancer, transplantation, autoimmune diseases, and other immunodeficiencies require new integrated strategies of novel immunotherapeutics, antimicrobial therapy, and rapid molecular diagnostics. These strategies are essential for being able to combat life-threatening infections in our immunocompromised host populations. Therefore, a new center is being established in order to provide a powerful engine of translational research from pre-clinical studies to patient-oriented clinical trials for the diagnosis, treatment, and prevention of life-threatening infections in immunocompromised patients with cancer.